{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:05:52Z","timestamp":1790075152388,"version":"4.0.1"},"reference-count":68,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangxi Science and Technology Development Projects","award":["14124003-4"],"award-info":[{"award-number":["14124003-4"]}]},{"name":"The National Science and Technology Major Special Project","award":["2012ZX10002010001009"],"award-info":[{"award-number":["2012ZX10002010001009"]}]},{"name":"Guangxi University of Science and Technology Research Projects","award":["KY2015LX056"],"award-info":[{"award-number":["KY2015LX056"]}]},{"name":"Self-Raised Scientific Research","award":["Z2015621"],"award-info":[{"award-number":["Z2015621"]}]},{"name":"Self-Raised Scientific Research","award":["Z2014241"],"award-info":[{"award-number":["Z2014241"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aims to clarify the relationship and mechanism between expression of autophagy\u2010related protein P62 and prognosis of patients with hepatocellular carcinoma (<jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content>) involving chronic hepatitis B virus (<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>) infection and aflatoxin B1 (<jats:styled-content style=\"fixed-case\">AFB<\/jats:styled-content>1) exposure. <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content> patients who underwent resection were divided into three groups: <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>(+)\/<jats:styled-content style=\"fixed-case\">AFB<\/jats:styled-content>1(+) (<jats:italic>n<\/jats:italic>\u00a0=\u00a026), <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>(+)\/<jats:styled-content style=\"fixed-case\">AFB<\/jats:styled-content>1(\u2212) (<jats:italic>n<\/jats:italic>\u00a0=\u00a068), and <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>(\u2212)\/<jats:styled-content style=\"fixed-case\">AFB<\/jats:styled-content>1(\u2212) (<jats:italic>n<\/jats:italic>\u00a0=\u00a014). The groups were compared in terms of <jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content> and protein levels of P62, disease\u2010free survival (<jats:styled-content style=\"fixed-case\">DFS<\/jats:styled-content>), and overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) and the expression of <jats:styled-content style=\"fixed-case\">NRF<\/jats:styled-content>2, Nqo1, and <jats:styled-content style=\"fixed-case\">AKR<\/jats:styled-content>7A3 in P62 high\u2010expression and low\u2010expression group. <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>(+)\/<jats:styled-content style=\"fixed-case\">AFB<\/jats:styled-content>1(+) group has lower <jats:styled-content style=\"fixed-case\">DFS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>, and higher P62 expression than in the other two groups. P62 expression generally correlated with elevated <jats:styled-content style=\"fixed-case\">NRF<\/jats:styled-content>2 and Nqo1 expression, and reduced <jats:styled-content style=\"fixed-case\">AKR<\/jats:styled-content>7A3 expression. Patients expressing high levels of P62 showed significantly lower <jats:styled-content style=\"fixed-case\">DFS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> rates than patients expressing low levels. <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content> involving <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> infection and <jats:styled-content style=\"fixed-case\">AFB<\/jats:styled-content>1 exposure is associated with relatively high risk of tumor recurrence, and this poor prognosis may relate to high P62 expression. High P62 expression activates the <jats:styled-content style=\"fixed-case\">NRF<\/jats:styled-content>2 pathway, promotes tumor recurrence. The downregulation of <jats:styled-content style=\"fixed-case\">AKR<\/jats:styled-content>7A3 also reduced liver detoxification of aflatoxin B1.<\/jats:p>","DOI":"10.1002\/cam4.1176","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T10:46:53Z","timestamp":1505990813000},"page":"2357-2369","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure"],"prefix":"10.1002","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-0196","authenticated-orcid":false,"given":"Xiao","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong\u2010Gui","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue\u2010Mei","family":"You","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"},{"name":"Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan\u2010Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u2010Nan","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"},{"name":"Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"},{"name":"Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang\u2010De","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"},{"name":"Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-6396","authenticated-orcid":false,"given":"Jian\u2010Hong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"},{"name":"Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u2010Qun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Affiliated Tumor Hospital of Guangxi Medical University Guangxi Cancer Institute Hospital Oncology School Guangxi Cancer Center  Nanning 530021 China"},{"name":"Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center  Nanning 530021 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24199"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2012.13.3.743"},{"key":"e_1_2_7_6_1","first-page":"352","article-title":"Epidemiology, risk factors and surveillance of hepatocellular carcinoma","volume":"14","author":"Cabibbo G.","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"e_1_2_7_7_1","first-page":"2506","article-title":"Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China","volume":"49","author":"Yeh F. S.","year":"1989","journal-title":"Cancer Res."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.1999.0047"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.01.006"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2015.032"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30782"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115834"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000236"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0901388"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1169"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.11.018"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.4.535"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.09.020"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1565::AID-CNCR10>3.0.CO;2-9"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5742(00)00026-0"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.002"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2009.02.057"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10176"},{"key":"e_1_2_7_24_1","first-page":"757","article-title":"[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis]","volume":"24","author":"Xue K. X.","year":"2005","journal-title":"Ai Zheng"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2003.00869.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(01)00697-7"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068193"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1997.tb00513.x"},{"key":"e_1_2_7_29_1","first-page":"2749","article-title":"Glutathione S\u2010transferase expression in hepatitis B virus\u2010associated human hepatocellular carcinogenesis","volume":"57","author":"Zhou T.","year":"1997","journal-title":"Cancer. Res."},{"key":"e_1_2_7_30_1","first-page":"45","article-title":"Molecular dosimetry of urinary aflatoxin\u2010DNA adducts in people living in Guangxi autonomous region, People's Republic of China","volume":"52","author":"Groopman J. D.","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-13-0430"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/1547691X.2014.925994"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1946"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2007.04.024"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.08.003"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201102031"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.10.025"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.03.048"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.05.008"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2016211"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2008.01.012"},{"key":"e_1_2_7_42_1","first-page":"3220","article-title":"p53 Mutations in human hepatocellular carcinomas from Germany","volume":"52","author":"Kress S.","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_7_43_1","first-page":"6358","article-title":"p53 gene mutation spectrum in hepatocellular carcinoma","volume":"52","author":"Oda T.","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-010-9140-5"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02572.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12460"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2014.867947"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22581"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911373107"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.118976"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.12.006"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5003"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2256"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3252"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2010.01473.x"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.225680.113"},{"key":"e_1_2_7_57_1","article-title":"AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c\u2010Jun and NF\u2010kappaB signaling pathways","author":"Chow R. K.","year":"2016","journal-title":"Oncotarget"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.140.5.450"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.06.004"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21931"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0524-9"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000396"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.03.024"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.091"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001426"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1159\/000348669"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2661-6"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0065"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027326"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.1176","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.1176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:57:34Z","timestamp":1695999454000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.1176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1002\/cam4.1176"],"URL":"https:\/\/doi.org\/10.1002\/cam4.1176","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]},"assertion":[{"value":"2017-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}